News & Media

Explore the latest news from our company and stay up-to-date with our upcoming events.

Key figures

  • 21.2

    billion euro net sales in 2024

  • 6.1

    billion euro EBITDA pre in 2024

  • 62000

    employees around the world

Latest News

View all news
  1. Press Releases

    Merck KGaA, Darmstadt, Germany Announces Publication of Long-Term Efficacy ...

    SpringWorks Therapeutics announced long-term efficacy and safety data from the DeFi trial of OGSIVEO to be published in JCO.

    2025/10/21

  2. Press Releases

    Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued ...

    Merck KGaA, Darmstadt, Germany today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib.

    2025/10/17

  3. Press Releases

    Capital Markets Day 2025: Ready for the Next Wave of Growth

    Merck KGaA, Darmstadt, Germany, is well-positioned for the next wave of growth following strategic portfolio streamlining and targeted investments.

    2025/10/16

Stay up-to-date

You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe

  • Media Contacts

    for journalists, bloggers or multipliers.

    Get in touch!
  • Media downloads

    Browse and download high-quality images and video footage.
    Access gallery
  • Press Kits

    with all the facts and relevant background information on particularly important topics.

    Collected Topics
  • Strategy & Values

    We believe in science and technology as a force for good.

    Learn more
  • Stories

    Learn more about our company and the people behind it.

    Learn more
  • Sustainability

    We want to create long-term added value for society.

    Learn more
  • Our sites

    Learn where you can find us around the world.

    Learn more

Upcoming Events

View All Events